Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole
2. Gsk052
3. Gsk2251052
1. 1093643-37-8
2. Gsk-2251052
3. Epetraborole [inn]
4. An3365
5. Gsk2251052
6. An-3365
7. (s)-3-(aminomethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3h)-ol
8. 6mc93z2df9
9. 3-[[(3s)-3-(aminomethyl)-1-hydroxy-3h-2,1-benzoxaborol-7-yl]oxy]propan-1-ol
10. 1-propanol, 3-(((3s)-3-(aminomethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)oxy)-
11. Unii-6mc93z2df9
12. Gsk 2251052
13. An3365; Epetraborole
14. Epetraborole [who-dd]
15. Schembl1498692
16. Chembl3549142
17. Dtxsid20148913
18. Bcp18025
19. Ex-a2426
20. Zinc198027014
21. Db11744
22. Ac-35364
23. Ac-36068
24. Q27265149
25. (3s)-3-(aminomethyl)-7-(3-hydroxypropoxy)-1,3-dihydro-2,1-benzoxaborol-1-ol
| Molecular Weight | 237.06 g/mol |
|---|---|
| Molecular Formula | C11H16BNO4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 237.1172382 g/mol |
| Monoisotopic Mass | 237.1172382 g/mol |
| Topological Polar Surface Area | 84.9 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 244 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Epetraborole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epetraborole, including repackagers and relabelers. The FDA regulates Epetraborole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epetraborole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Epetraborole supplier is an individual or a company that provides Epetraborole active pharmaceutical ingredient (API) or Epetraborole finished formulations upon request. The Epetraborole suppliers may include Epetraborole API manufacturers, exporters, distributors and traders.
Epetraborole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Epetraborole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Epetraborole GMP manufacturer or Epetraborole GMP API supplier for your needs.
A Epetraborole CoA (Certificate of Analysis) is a formal document that attests to Epetraborole's compliance with Epetraborole specifications and serves as a tool for batch-level quality control.
Epetraborole CoA mostly includes findings from lab analyses of a specific batch. For each Epetraborole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Epetraborole may be tested according to a variety of international standards, such as European Pharmacopoeia (Epetraborole EP), Epetraborole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epetraborole USP).
LOOKING FOR A SUPPLIER?
